Get quick answers to your questions about the article from our AI researcher chatbot
{'id': 'https://openalex.org/W2328289254', 'doi': 'https://doi.org/10.1093/infdis/167.2.494', 'title': 'The Activity of Atovaquone (566C80) in Murine Toxoplasmosis Is Markedly Augmented when Used in Combination with Pyrimethamine or Sulfadiazine', 'display_name': 'The Activity of Atovaquone (566C80) in Murine Toxoplasmosis Is Markedly Augmented when Used in Combination with Pyrimethamine or Sulfadiazine', 'publication_year': 1993, 'publication_date': '1993-02-01', 'ids': {'openalex': 'https://openalex.org/W2328289254', 'doi': 'https://doi.org/10.1093/infdis/167.2.494', 'mag': '2328289254', 'pmid': 'https://pubmed.ncbi.nlm.nih.gov/8421189'}, 'language': 'en', 'primary_location': {'is_oa': False, 'landing_page_url': 'https://doi.org/10.1093/infdis/167.2.494', 'pdf_url': None, 'source': {'id': 'https://openalex.org/S54542293', 'display_name': 'The Journal of Infectious Diseases', 'issn_l': '0022-1899', 'issn': ['0022-1899', '1537-6613'], 'is_oa': False, 'is_in_doaj': False, 'is_core': True, 'host_organization': 'https://openalex.org/P4310311648', 'host_organization_name': 'Oxford University Press', 'host_organization_lineage': ['https://openalex.org/P4310311647', 'https://openalex.org/P4310311648'], 'host_organization_lineage_names': ['University of Oxford', 'Oxford University Press'], 'type': 'journal'}, 'license': None, 'license_id': None, 'version': None, 'is_accepted': False, 'is_published': False}, 'type': 'article', 'type_crossref': 'journal-article', 'indexed_in': ['crossref', 'pubmed'], 'open_access': {'is_oa': False, 'oa_status': 'closed', 'oa_url': None, 'any_repository_has_fulltext': False}, 'authorships': [{'author_position': 'first', 'author': {'id': 'https://openalex.org/A5111987861', 'display_name': 'Fausto G. Araujo', 'orcid': None}, 'institutions': [{'id': 'https://openalex.org/I97018004', 'display_name': 'Stanford University', 'ror': 'https://ror.org/00f54p054', 'country_code': 'US', 'type': 'education', 'lineage': ['https://openalex.org/I97018004']}, {'id': 'https://openalex.org/I4210124598', 'display_name': 'Palo Alto Institute', 'ror': 'https://ror.org/02xf01n45', 'country_code': 'US', 'type': 'nonprofit', 'lineage': ['https://openalex.org/I4210124598']}], 'countries': ['US'], 'is_corresponding': False, 'raw_author_name': 'Fausto G. Araujo', 'raw_affiliation_strings': ['Research Institute, Palo Alto Medical Foundation, Palo Alto, and Stanford University Medical School, Stanford, California'], 'affiliations': [{'raw_affiliation_string': 'Research Institute, Palo Alto Medical Foundation, Palo Alto, and Stanford University Medical School, Stanford, California', 'institution_ids': ['https://openalex.org/I97018004', 'https://openalex.org/I4210124598']}]}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5110347505', 'display_name': 'Teri Lin', 'orcid': None}, 'institutions': [{'id': 'https://openalex.org/I4210124598', 'display_name': 'Palo Alto Institute', 'ror': 'https://ror.org/02xf01n45', 'country_code': 'US', 'type': 'nonprofit', 'lineage': ['https://openalex.org/I4210124598']}, {'id': 'https://openalex.org/I97018004', 'display_name': 'Stanford University', 'ror': 'https://ror.org/00f54p054', 'country_code': 'US', 'type': 'education', 'lineage': ['https://openalex.org/I97018004']}], 'countries': ['US'], 'is_corresponding': False, 'raw_author_name': 'Teri Lin', 'raw_affiliation_strings': ['Research Institute, Palo Alto Medical Foundation, Palo Alto, and Stanford University Medical School, Stanford, California'], 'affiliations': [{'raw_affiliation_string': 'Research Institute, Palo Alto Medical Foundation, Palo Alto, and Stanford University Medical School, Stanford, California', 'institution_ids': ['https://openalex.org/I4210124598', 'https://openalex.org/I97018004']}]}, {'author_position': 'last', 'author': {'id': 'https://openalex.org/A5109840575', 'display_name': 'Jack S. Remington', 'orcid': None}, 'institutions': [{'id': 'https://openalex.org/I4210124598', 'display_name': 'Palo Alto Institute', 'ror': 'https://ror.org/02xf01n45', 'country_code': 'US', 'type': 'nonprofit', 'lineage': ['https://openalex.org/I4210124598']}, {'id': 'https://openalex.org/I97018004', 'display_name': 'Stanford University', 'ror': 'https://ror.org/00f54p054', 'country_code': 'US', 'type': 'education', 'lineage': ['https://openalex.org/I97018004']}], 'countries': ['US'], 'is_corresponding': False, 'raw_author_name': 'Jack S. Remington', 'raw_affiliation_strings': ['Research Institute, Palo Alto Medical Foundation, Palo Alto, and Stanford University Medical School, Stanford, California'], 'affiliations': [{'raw_affiliation_string': 'Research Institute, Palo Alto Medical Foundation, Palo Alto, and Stanford University Medical School, Stanford, California', 'institution_ids': ['https://openalex.org/I4210124598', 'https://openalex.org/I97018004']}]}], 'institution_assertions': [], 'countries_distinct_count': 1, 'institutions_distinct_count': 2, 'corresponding_author_ids': [], 'corresponding_institution_ids': [], 'apc_list': {'value': 4320, 'currency': 'USD', 'value_usd': 4320, 'provenance': 'doaj'}, 'apc_paid': None, 'fwci': 4.611, 'has_fulltext': True, 'fulltext_origin': 'ngrams', 'cited_by_count': 60, 'citation_normalized_percentile': {'value': 0.879803, 'is_in_top_1_percent': False, 'is_in_top_10_percent': False}, 'cited_by_percentile_year': {'min': 93, 'max': 94}, 'biblio': {'volume': '167', 'issue': '2', 'first_page': '494', 'last_page': '497'}, 'is_retracted': False, 'is_paratext': False, 'primary_topic': {'id': 'https://openalex.org/T11155', 'display_name': 'Toxoplasma gondii Research Studies', 'score': 0.9998, 'subfield': {'id': 'https://openalex.org/subfields/2405', 'display_name': 'Parasitology'}, 'field': {'id': 'https://openalex.org/fields/24', 'display_name': 'Immunology and Microbiology'}, 'domain': {'id': 'https://openalex.org/domains/1', 'display_name': 'Life Sciences'}}, 'topics': [{'id': 'https://openalex.org/T11155', 'display_name': 'Toxoplasma gondii Research Studies', 'score': 0.9998, 'subfield': {'id': 'https://openalex.org/subfields/2405', 'display_name': 'Parasitology'}, 'field': {'id': 'https://openalex.org/fields/24', 'display_name': 'Immunology and Microbiology'}, 'domain': {'id': 'https://openalex.org/domains/1', 'display_name': 'Life Sciences'}}, {'id': 'https://openalex.org/T10526', 'display_name': 'HIV/AIDS drug development and treatment', 'score': 0.9977, 'subfield': {'id': 'https://openalex.org/subfields/2725', 'display_name': 'Infectious Diseases'}, 'field': {'id': 'https://openalex.org/fields/27', 'display_name': 'Medicine'}, 'domain': {'id': 'https://openalex.org/domains/4', 'display_name': 'Health Sciences'}}, {'id': 'https://openalex.org/T10112', 'display_name': 'HIV Research and Treatment', 'score': 0.9975, 'subfield': {'id': 'https://openalex.org/subfields/2406', 'display_name': 'Virology'}, 'field': {'id': 'https://openalex.org/fields/24', 'display_name': 'Immunology and Microbiology'}, 'domain': {'id': 'https://openalex.org/domains/1', 'display_name': 'Life Sciences'}}], 'keywords': [{'id': 'https://openalex.org/keywords/atovaquone', 'display_name': 'Atovaquone', 'score': 0.9917234}, {'id': 'https://openalex.org/keywords/toxoplasmosis', 'display_name': 'Toxoplasmosis', 'score': 0.8280731}], 'concepts': [{'id': 'https://openalex.org/C2779124865', 'wikidata': 'https://www.wikidata.org/wiki/Q418179', 'display_name': 'Atovaquone', 'level': 4, 'score': 0.9917234}, {'id': 'https://openalex.org/C2778269047', 'wikidata': 'https://www.wikidata.org/wiki/Q2555060', 'display_name': 'Sulfadiazine', 'level': 3, 'score': 0.9748446}, {'id': 'https://openalex.org/C2777035104', 'wikidata': 'https://www.wikidata.org/wiki/Q421072', 'display_name': 'Pyrimethamine', 'level': 4, 'score': 0.9448792}, {'id': 'https://openalex.org/C2778062946', 'wikidata': 'https://www.wikidata.org/wiki/Q154878', 'display_name': 'Toxoplasmosis', 'level': 2, 'score': 0.8280731}, {'id': 'https://openalex.org/C2778128430', 'wikidata': 'https://www.wikidata.org/wiki/Q131003', 'display_name': 'Toxoplasma gondii', 'level': 3, 'score': 0.61310035}, {'id': 'https://openalex.org/C71924100', 'wikidata': 'https://www.wikidata.org/wiki/Q11190', 'display_name': 'Medicine', 'level': 0, 'score': 0.5265311}, {'id': 'https://openalex.org/C98274493', 'wikidata': 'https://www.wikidata.org/wiki/Q128406', 'display_name': 'Pharmacology', 'level': 1, 'score': 0.45771068}, {'id': 'https://openalex.org/C159047783', 'wikidata': 'https://www.wikidata.org/wiki/Q7215', 'display_name': 'Virology', 'level': 1, 'score': 0.44579035}, {'id': 'https://openalex.org/C203014093', 'wikidata': 'https://www.wikidata.org/wiki/Q101929', 'display_name': 'Immunology', 'level': 1, 'score': 0.42728168}, {'id': 'https://openalex.org/C2778048844', 'wikidata': 'https://www.wikidata.org/wiki/Q12156', 'display_name': 'Malaria', 'level': 2, 'score': 0.28560966}, {'id': 'https://openalex.org/C89423630', 'wikidata': 'https://www.wikidata.org/wiki/Q7193', 'display_name': 'Microbiology', 'level': 1, 'score': 0.28372365}, {'id': 'https://openalex.org/C86803240', 'wikidata': 'https://www.wikidata.org/wiki/Q420', 'display_name': 'Biology', 'level': 0, 'score': 0.26090628}, {'id': 'https://openalex.org/C501593827', 'wikidata': 'https://www.wikidata.org/wiki/Q12187', 'display_name': 'Antibiotics', 'level': 2, 'score': 0.22550356}, {'id': 'https://openalex.org/C2777425658', 'wikidata': 'https://www.wikidata.org/wiki/Q422438', 'display_name': 'Chloroquine', 'level': 3, 'score': 0.1710608}, {'id': 'https://openalex.org/C159654299', 'wikidata': 'https://www.wikidata.org/wiki/Q79460', 'display_name': 'Antibody', 'level': 2, 'score': 0.068083555}, {'id': 'https://openalex.org/C2778371730', 'wikidata': 'https://www.wikidata.org/wiki/Q311383', 'display_name': 'Plasmodium falciparum', 'level': 3, 'score': 0.05889398}], 'mesh': [{'descriptor_ui': 'D000981', 'descriptor_name': 'Antiprotozoal Agents', 'qualifier_ui': 'Q000627', 'qualifier_name': 'therapeutic use', 'is_major_topic': True}, {'descriptor_ui': 'D009285', 'descriptor_name': 'Naphthoquinones', 'qualifier_ui': 'Q000627', 'qualifier_name': 'therapeutic use', 'is_major_topic': True}, {'descriptor_ui': 'D011739', 'descriptor_name': 'Pyrimethamine', 'qualifier_ui': 'Q000627', 'qualifier_name': 'therapeutic use', 'is_major_topic': True}, {'descriptor_ui': 'D013411', 'descriptor_name': 'Sulfadiazine', 'qualifier_ui': 'Q000627', 'qualifier_name': 'therapeutic use', 'is_major_topic': True}, {'descriptor_ui': 'D014124', 'descriptor_name': 'Toxoplasmosis, Animal', 'qualifier_ui': 'Q000188', 'qualifier_name': 'drug therapy', 'is_major_topic': True}, {'descriptor_ui': 'D000818', 'descriptor_name': 'Animals', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D000981', 'descriptor_name': 'Antiprotozoal Agents', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D053626', 'descriptor_name': 'Atovaquone', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D004357', 'descriptor_name': 'Drug Synergism', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D004359', 'descriptor_name': 'Drug Therapy, Combination', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D005260', 'descriptor_name': 'Female', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D051379', 'descriptor_name': 'Mice', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D009285', 'descriptor_name': 'Naphthoquinones', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D011739', 'descriptor_name': 'Pyrimethamine', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D013411', 'descriptor_name': 'Sulfadiazine', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D014124', 'descriptor_name': 'Toxoplasmosis, Animal', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}], 'locations_count': 2, 'locations': [{'is_oa': False, 'landing_page_url': 'https://doi.org/10.1093/infdis/167.2.494', 'pdf_url': None, 'source': {'id': 'https://openalex.org/S54542293', 'display_name': 'The Journal of Infectious Diseases', 'issn_l': '0022-1899', 'issn': ['0022-1899', '1537-6613'], 'is_oa': False, 'is_in_doaj': False, 'is_core': True, 'host_organization': 'https://openalex.org/P4310311648', 'host_organization_name': 'Oxford University Press', 'host_organization_lineage': ['https://openalex.org/P4310311647', 'https://openalex.org/P4310311648'], 'host_organization_lineage_names': ['University of Oxford', 'Oxford University Press'], 'type': 'journal'}, 'license': None, 'license_id': None, 'version': None, 'is_accepted': False, 'is_published': False}, {'is_oa': False, 'landing_page_url': 'https://pubmed.ncbi.nlm.nih.gov/8421189', 'pdf_url': None, 'source': {'id': 'https://openalex.org/S4306525036', 'display_name': 'PubMed', 'issn_l': None, 'issn': None, 'is_oa': False, 'is_in_doaj': False, 'is_core': False, 'host_organization': 'https://openalex.org/I1299303238', 'host_organization_name': 'National Institutes of Health', 'host_organization_lineage': ['https://openalex.org/I1299303238'], 'host_organization_lineage_names': ['National Institutes of Health'], 'type': 'repository'}, 'license': None, 'license_id': None, 'version': None, 'is_accepted': False, 'is_published': False}], 'best_oa_location': None, 'sustainable_development_goals': [{'score': 0.84, 'id': 'https://metadata.un.org/sdg/3', 'display_name': 'Good health and well-being'}], 'grants': [], 'datasets': [], 'versions': [], 'referenced_works_count': 8, 'referenced_works': ['https://openalex.org/W1833207062', 'https://openalex.org/W1965527205', 'https://openalex.org/W2003682354', 'https://openalex.org/W2012789887', 'https://openalex.org/W2118833767', 'https://openalex.org/W2128631240', 'https://openalex.org/W2322334823', 'https://openalex.org/W2340127688'], 'related_works': ['https://openalex.org/W4230614452', 'https://openalex.org/W2461196744', 'https://openalex.org/W2405062015', 'https://openalex.org/W2400966550', 'https://openalex.org/W2338582275', 'https://openalex.org/W2328289254', 'https://openalex.org/W2087668195', 'https://openalex.org/W2052997048', 'https://openalex.org/W2027183849', 'https://openalex.org/W111668322'], 'abstract_inverted_index': {'The': [0], 'activity': [1], 'of': [2, 7, 26, 30, 37, 66, 97, 105], 'atovaquone': [3, 54, 60, 106], 'in': [4, 15, 80, 99], 'the': [5, 73, 103], 'treatment': [6, 96], 'murine': [8], 'toxoplasmosis': [9, 98], 'was': [10, 61], 'greatly': [11], 'enhanced': [12], 'when': [13, 45, 51, 85], 'administered': [14, 46], 'combination': [16, 104], 'with': [17, 23, 35, 87, 107], 'pyrimethamine': [18, 52, 67, 110], 'or': [19, 28, 40, 109], 'sulfadiazine.': [20], 'Mice': [21], 'infected': [22, 81], 'lethal': [24], 'inocula': [25], 'tachyzoites': [27], 'cysts': [29], 'Toxoplasma': [31], 'gondii': [32], 'and': [33, 55], 'treated': [34], 'doses': [36, 65, 74], 'atovaquone,': [38], 'pyrimethamine,': [39], 'sulfadiazine': [41, 58, 70, 108], 'that': [42, 75, 92], 'were': [43, 83], 'ineffective': [44], 'alone': [47], 'had': [48], '70%': [49], 'survival': [50], 'plus': [53, 59], '100%': [56], 'survivalwhen': [57], 'used.': [62], 'Of': [63], 'interest,': [64], 'and,': [68], 'particularly,': [69], 'far': [71], 'below': [72], 'would': [76], 'induce': [77], 'any': [78], 'protection': [79], 'mice': [82], 'active': [84], 'combined': [86], 'atovaquone.': [88], 'These': [89], 'results': [90], 'suggest': [91], 'clinical': [93], 'trials': [94], 'for': [95], 'AIDS': [100], 'patients': [101], 'using': [102], 'are': [111], 'justified.': [112]}, 'cited_by_api_url': 'https://api.openalex.org/works?filter=cites:W2328289254', 'counts_by_year': [{'year': 2024, 'cited_by_count': 1}, {'year': 2021, 'cited_by_count': 1}, {'year': 2019, 'cited_by_count': 2}, {'year': 2018, 'cited_by_count': 1}, {'year': 2017, 'cited_by_count': 1}, {'year': 2012, 'cited_by_count': 1}], 'updated_date': '2024-12-08T21:11:42.522182', 'created_date': '2016-06-24'}